ReviewEmerging infectious diseases2008
Emericella quadrilineata as cause of invasive aspergillosis.
Review in Emerging infectious diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 60 citations in OpenAlex.
- A Unique Case of Fungal Endometritis Caused byClinical case reports · 2025Article
- Accelerating the understanding ofCurrent research in microbial sciences · 2024Review
- Central nervous system Aspergillus quadrilineatus infection in a COVID-19 patient, a case report and literature review.Journal of clinical laboratory analysis · 2023Review
- Four New Species ofJournal of fungi (Basel, Switzerland) · 2022Article
- Functional Characterization of Clinical Isolates of the Opportunistic Fungal Pathogen Aspergillus nidulans.mSphere · 2020Article
- The first rare and fatal case of invasive aspergillosis of spinal cord due toCurrent medical mycology · 2020Article
- The Emergence of Rare ClinicalFrontiers in microbiology · 2019Article
- EmergingOpen forum infectious diseases · 2018Review
- Proven Invasive Pulmonary Aspergillosis in Stem Cell Transplant Recipient Due to Aspergillus sublatus, a Cryptic Species of A. nidulans.Mycopathologia · 2018Article
- Article
- Aspergillosis in Chronic Granulomatous Disease.Journal of fungi (Basel, Switzerland) · 2016Review
- The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.Mycopathologia · 2016Article
- Recurrent prosthetic valve endocarditis caused by Aspergillus delacroxii (formerly Aspergillus nidulans var. echinulatus).Medical mycology case reports · 2015Article
- Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.Journal of clinical microbiology · 2013Article
- Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry.Journal of clinical microbiology · 2013Article
- Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.Journal of clinical microbiology · 2012Article
- Invasive aspergillosis: resistance to antifungal drugs.Mycopathologia · 2012Review
- Aspergillus sect. Aeni sect. nov., a new section of the genus for A.karnatakaensis sp. nov. and some allied fungi.IMA fungus · 2010Article
- Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.Journal of clinical microbiology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 3 countries.
Funding
Abstract
We noted a cluster of 4 cases of infection or colonization by Emericella spp., identified by sequence-based analysis as E. quadrilineata. Sequence-based analysis of an international collection of 33 Emericella isolates identified 12 as E. nidulans, all 12 of which had previously been identified by morphologic methods as E. nidulans. For 12 isolates classified as E. quadrilineata, only 6 had been previously identified accordingly. E. nidulans was less susceptible than E. quadrilineata to amphotericin B (median MICs 2.5 and 0.5 mg/L, respectively, p<0.05); E. quadrilineata was less susceptible than E. nidulans to caspofungin (median MICs, 1.83 and 0.32 mg/L, respectively, p<0.05). These data indicate that sequence-based identification is more accurate than morphologic examination for identifying Emericella spp. and that correct species demarcation and in vitro susceptibility testing may affect patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.